Desk›Healthcare› Syngene International Ltd
Syngene International Ltd
BSE 539268 · NSE SYNGENE · ISIN INE398R01022 · Group A · Active
Healthcare › Healthcare › Healthcare Services › Healthcare Research, Analytics & Technology
₹403.40
-2.55%
BSE close, 28 August 2026
₹16,284.01 cr
40.4 cr shares · Small cap
₹7,639.43 cr
as published
71.2× · 3.77×
EPS ₹5.67 · BV ₹107.00
3,423.80 / 304.90
₹ cr, as filed
25
7 selected · 28%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -40.5% |
|---|---|
| Against 52-week low | +7.4% |
| Day change | -2.55% |
| Size band | Small cap |
| Index membership | NIFTY 500 |
Valuation as published by BSE
| Earnings per share | ₹5.67 |
|---|---|
| Price / earnings | 71.15× |
| Price / book | 3.77× |
| Book value — derived, price ÷ P/B | ₹107.00 |
| Return on equity | 5.30% |
| Operating margin | 13.53% |
| Net margin | -0.32% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 5.30%
- ROE as published
- 5.30%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 663.00 | -2.10 | -0.05 | 13.53% | -0.32% |
| Mar-26 · Q | 960.00 | 148.20 | 3.68 | 31.09% | 15.44% |
| FY25-26 | 3,423.80 | 304.90 | 7.58 | 23.61% | 8.91% |
Quarter on quarter
- Revenue, quarter on quarter
- -30.9%
- Net profit, quarter on quarter
- -101.4%
- Operating margin, quarter on quarter
- -1,756 bps
Disclosure profile 25 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Change in Management | 2 |
| Acquisition | 1 |
| Board Outcome | 1 |
| Investor Presentation | 1 |
| Press Release | 1 |
| Results | 1 |
| Selected sub-total | 7 |
| Procedural | |
| Analyst / Investor Meet | 8 |
| General | 3 |
| AGM / EGM | 2 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| Newspaper Publication | 1 |
| SAST | 1 |
| Trading Window | 1 |
| Procedural sub-total | 18 |
| Total | 25 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
25 filings · 7 selected · busiest 2026-07-29
Filing rhythm · the twelve most recent
2026-08-242026-10-08
SelectedProcedural
Filings
25 in the window · 17 earlier on record
-
8 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
8 October 2026 ·
Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ending September 30, 2026.
Syngene International Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2026 ,inter alia, to consider and approve the Un-Audited Standalone ....
Board Meeting / Board Meeting View filing →
-
25 September 2026 ·
Closure of Trading Window
Intimation of Closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
24 September 2026 ·
Intimation Of Cancellation Of Meeting With Analyst/Institutional Investors
Intimation of cancellation of meeting with Analyst/Institutional Investors
Company Update / General View filing →
-
21 September 2026 ·
Change in Management
Resignation of Mr. Pramuch Goel as Head Corporate Affairs & Communications and a member of Executive Committee (Senior Management Personnel) of the Company w.e.f. the close of business ....
Company Update / Change in Management View filing →
-
21 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Schedule of Meeting with Analyst/Institutional Investor
Company Update / Analyst / Investor Meet View filing →
-
11 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Schedule of Meeting with Analyst/Institutional Investor
Company Update / Analyst / Investor Meet View filing →
-
10 September 2026 ·
Communication Regarding Remittance Of Final Dividend For The FY 2025-26
Communication regarding remittance of final dividend for the FY 2025-26
Company Update / General View filing →
-
1 September 2026 ·
Grant Of Performance Share Units Under Syngene Long Term Inc entive Performance Share Plan (PSP) 2023 ('Plan')
Grant of Performance Share Units under Syngene Long Term Inc entive Performance Share Plan (PSP) 2023 ("Plan")
Company Update / General View filing →
-
25 August 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Schedule of Investor/Analyst Meeting with Goldman Sachs Asia Leaders Conference 2026
Company Update / Analyst / Investor Meet View filing →
-
24 August 2026 ·
Acquisition
Intimation of investment in Ampin C&I Power Twelve Private Limited
Company Update / Acquisition View filing →
-
24 August 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Investor call schedule with Entrust Family Office
Company Update / Analyst / Investor Meet View filing →
-
10 August 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Schedule of Meeting with Analyst/Institutional Investor on August 13, 2026 and August 14, 2026.
Company Update / Analyst / Investor Meet View filing →
-
6 August 2026 ·
Analyst / Investor Meet - Outcome
Intimation of Earnings Conference call transcript for Q1 FY2027
Company Update / Analyst / Investor Meet View filing →
-
31 July 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Scrutinizer's Report and voting results of 33rd Annual General Meeting
AGM/EGM / AGM View filing →
-
30 July 2026 ·
Analyst / Investor Meet - Outcome
Intimation of audio recording for Q1 FY27 post-earnings call
Company Update / Analyst / Investor Meet View filing →
-
30 July 2026 ·
Newspaper Publication
Newspaper Advertisement - Financial Results
Company Update / Newspaper Publication View filing →
-
29 July 2026 ·
-
29 July 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 33rd Annual General Meeting
AGM/EGM / AGM View filing →
-
29 July 2026 ·
Change in Management
Resignation of Independent Director
Company Update / Change in Management View filing →
-
29 July 2026 ·
Press Release / Media Release
Press Release
Company Update / Press Release / Media Release View filing →
-
29 July 2026 ·
Results - Financial Results For Quarter Ended June 30, 2026
Results - Financial Results for quarter ended June 30, 2026
Result / Financial Results View filing →
-
29 July 2026 ·
Board Meeting Outcome for Outcome Of The Board Meeting Held On July 29, 2026
Outcome of the Board Meeting held on July 29, 2026
Board Meeting / Outcome of Board Meeting View filing →
-
22 July 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Conference Call with Analysts and Investors.
Company Update / Analyst / Investor Meet View filing →
-
22 July 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mirae Asset Mutual Fund
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
RSS feed for Syngene International Ltd · the 50 most recent filings